Approval Probability 71%
TA Base Rate26%
Adjusted LOA41%
ML RiskLOW_RISK
| NCT ID | Title | Phase | Status | Enrollment | Velocity | Design | Start | Completion | Last Updated | Sites | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NCT00840320 | Repeat Dose Safety Study for Compound to Treat Anemia | PHASE1 | COMPLETED | 24 | — | — | Mar 13, 2009 | Sep 2, 2009 | Jun 22, 2017 | 1 | Australia |
| Arm | Type | Description |
|---|---|---|
| 1 | EXPERIMENTAL | Repeat doses of active at escalating doses |
| 2 | PLACEBO_COMPARATOR | Repeat doses of placebo |
| Name | Type | Description |
|---|---|---|
| 1278863 | DRUG | 15mg, 25mg, 50mg, 150mg |
| Placebo | DRUG | matching placebo |
Inclusion Criteria: 1. Healthy as determined by a responsible physician, based on a medical evaluation including medical history, physical examination, laboratory tests and cardiac monitoring. 2. Male or female between 18 and 55 years of age, inclusive. 3. A female subject must be of non-childbeari...